Bio-Techne
TECH
535 hedge funds and large institutions have $10.9B invested in Bio-Techne in 2022 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 213 increasing their positions, 180 reducing their positions, and 56 closing their positions.
231% more call options, than puts
Call options by funds: $16.1M | Put options by funds: $4.86M
18% more repeat investments, than reductions
Existing positions increased: 213 | Existing positions reduced: 180
11.04% more ownership
Funds ownership: 379.13% → 390.17% (+11%)
3% less funds holding
Funds holding: 549 → 535 (-14)
14% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 56
16% less capital invested
Capital invested by funds: $12.9B → $10.9B (-$2.02B)
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$86.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$73.3M |
| 3 |
Amundi
Paris,
France
|
+$56.6M |
| 4 |
Select Equity Group
New York
|
+$55.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$46.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$60.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$35.7M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$29.2M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$28.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$27.2M |
TECH Hedge Fund Activity: Q3 2022 in Review
535 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2022, worth a combined $10.9B — down 16% from $12.9B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of TECH and 48 opened new positions — a net loss of 8 holders — while 180 trimmed existing stakes and 213 added.
The largest buyer was Janus Henderson Group, adding an estimated $86.1M. The largest seller was Massachusetts Financial Services, cutting an estimated $60.9M.
- 535 institutional investors held Bio-Techne (TECH) as of Q3 2022, down from 549 in Q2 2022.
- Funds reported $10.9B of Bio-Techne stock for Q3 2022, down 16% quarter-over-quarter.
- 48 funds opened new Bio-Techne positions in Q3 2022 and 56 closed out, a net change of -8 holders.
- The largest Bio-Techne buyer in Q3 2022 was Janus Henderson Group, an estimated $86.1M added.
- The largest Bio-Techne seller in Q3 2022 was Massachusetts Financial Services, an estimated $60.9M sold.
Based on aggregated 13F filings for Q3 2022.